Hepatocellular carcinoma – a complicated matter

1 Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598-1606; DOI:10.1016/j.jhep.2022.08.021. Search in Google Scholar

2 Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6; DOI:10.1038/s41572-020-00240-3. Search in Google Scholar

3 Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448-58; DOI:10.1038/nrgastro.2010.100. Search in Google Scholar

4 Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino EC, da Silva RF, da Silva RC, Goloni-Bertollo EM. Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac J Cancer Prev. 2017;18(4):863-72; DOI:10.22034/APJCP.2017.18.4.863. Search in Google Scholar

5 OECD. Understanding the socio-economic divide in Europe. Background report [Internet]. Paris: OECD; 2017 [cited: 2023 Nov 20]. 27 p. Available from: https://www.oecd.org/inclusive-growth/about/centre-for--opportunity-and-equality/understanding-the-socio-economic-divide--in-europe-26-january.htm/. Search in Google Scholar

6 Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, Rahman MH. Poverty and access to health care in developing countries. Ann NY Acad Sci. 2008;1136:161-71; DOI:10.1196/annals.1425.011. Search in Google Scholar

7 Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol. 2011;17(2):87-95; DOI:10.3350/kjhep.2011.17.2.87. Search in Google Scholar

8 Aaron D, Nagu TJ, Rwegasha J, Komba E. Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why? BMC Infect Dis. 2017;17(1):786; DOI:10.1186/s12879-017-2893-8. Search in Google Scholar

9 Shrestha DB, Khadka M, Khadka M, Subedi P, Pokharel S, Thapa BB. Hepatitis B vaccination status and knowledge, attitude, and practice regarding Hepatitis B among preclinical medical students of a medical college in Nepal. PLoS One. 2020;15(11):e0242658; DOI:10.1371/journal.pone.0242658. Search in Google Scholar

10 World Health Organization. Alcohol, total per capita (15+) consumption (in litres of pure alcohol) [Internet]. Geneva: WHO; 2010 [cited: 2023 Nov 25]. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption/. Search in Google Scholar

11 Office for National Statistics. Adult drinking habits in Great Britain: 2017 [Internet]. London: Office for National Statistics; [cited: 2023 Nov 25]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/bulletins/opinionsandlifestylesurveyadultdrinkinghabitsingreatbritain/2017/. Search in Google Scholar

12 Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52(2):252-7; DOI:10.1016/j.jhep.2009.11.015. Search in Google Scholar

13 Kew MC. Hepa tocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol. 2012;4(3):99-104; DOI:10.4254/wjh.v4.i3.99. Search in Google Scholar

14 Pinto Marques H, Gomes da Silva S, De Martin E, Agopian VG, Martins PN. Emerging biomarkers in HCC patients: current status. Int J Surg. 2020;82S:70-6; DOI:10.1016/j.ijsu.2020.04.043. Search in Google Scholar

15 Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study. Liver Transpl. 2023;29(10):1041-9; DOI:10.1097/LVT.0000000000000149 Search in Google Scholar

16 Holczbauer Á, Wangensteen KJ, Shin S. Cellular origins of regenerating liver and hepatocellular carcinoma. JHEP Rep. 2021;4(4):100416; DOI:10.1016/j.jhepr.2021.100416. Search in Google Scholar

17 Singh AK, Kumar R, Pandey AK. Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr Chem Genom Transl Med. 2018;12:9-26; DOI:10.2174/2213988501812010009. Search in Google Scholar

18 Zhang S, Liao Z, Li S, Luo Y. Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: a review. Medicine (Baltimore). 2023;102(42):e35571; DOI:10.1097/MD.0000000000035571. Search in Google Scholar

19 Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: prevention strategy and planning. World J Hepatol. 2015;7(12):1708-17; DOI:10.4254/wjh.v7.i12.1708. Search in Google Scholar

20 Parikh ND, Mehta AS, Singal AG, Block T, Marrero JA, Lok AS. Biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2495-503; DOI:10.1158/1055-9965. EPI-20-0005. Search in Google Scholar

21 Kudo M. Surveillance, diagnosis, and treatment outcome of Hepatocellular Carcinoma in Japan: 2023 Update. Liver Cancer. 2023;12(2):95-102; DOI:10.1159/000530079. Search in Google Scholar

22 Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. IJIAS. 2014;9(4):1718-23. Search in Google Scholar

23 UCSF Health. FAQ: Getting a liver transplant [Internet]. San Francisco: The University of California; 2023 [cited: 2023 Nov 26]. Available from: https://www.ucsfhealth.org/education/faq-getting-a-liver-transplant/. Search in Google Scholar

24 Cullen K, Jones M, Pockett RD, Burton A, Cross TJS, Rowe IA, Paley L, Tataru D, Alexander G, Marshall A, Fitzsimmons D. Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis. BMJ Open Gastroenterol. 2023;10(1):e000998; DOI:10.1136/bmjgast-2022-000998. Search in Google Scholar